Jazz Pharmaceuticals Plc is a company in the U.S. stock market and it is a holding in 123 U.S.-traded ETFs. JAZZ has around 3.6M shares in the U.S. ETF market. The largest ETF holder of JAZZ is the iShares NASDAQ Biotechnology ETF (IBB), with approximately 539.20K shares. Investors may also find of interest that the ETF with the largest allocation to JAZZ stock is Direxion Fallen Knives ETF (NIFE), with a portfolio weight of 5.54%. On average, U.S. ETFs allocate 0.40% of JAZZ to their portfolios.
Additionally, JAZZ is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with JAZZ as a holding is the ProShares Ultra NASDAQ Biotechnology (BIB), with a return of 47.60%.